Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary T Brophy

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
JAMIA Open|September 6, 2021
ProjectFlow: a configurable workflow management application for point of care researchRupali Dhond, Danne Elbers, Nilla Majahalme, et al.
Health Informatics Journal|March 30, 2026
Rule-based natural language processing to extract clinical trial and research study enrollment history from unstructured notesSergey D Goryachev, Julie Tsu-Yu Wu, Eric Lin, et al.
Seminars in Arthritis and Rheumatism|August 9, 2025
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trialSamantha Kohn, Harlan Sayles, Lindsay N Helget, et al.
American Journal of Epidemiology|July 31, 2018
The Gulf War Era Cohort and Biorepository: A Longitudinal Research Resource of Veterans of the 1990-1991 Gulf War EraLara Khalil, Rebecca B McNeil, Kellie J Sims, et al.
Arthritis Care & Research|August 7, 2025
Improvements in Health-Related Quality of Life with Treat-to-Target Urate-Lowering Therapy in Gout: A Post-hoc Analysis of a Randomized Multicenter TrialAustin Barry, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter TrialAustin Barry, Lindsay N Helget, Maria Androsenko, et al.
JAMA Network Open|June 30, 2026
Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric DisordersDavid T Liebers, Tianshe He, Rebecca A Betensky, et al.
Studies in Health Technology and Informatics|August 24, 2019
Machine Learning Methods to Predict Lung Cancer Survival Using the Veterans Affairs Research Precision Oncology Data CommonsNhan V Do, Jaime C Ramos, Nathanael R Fillmore, et al.
NEJM Evidence|April 18, 2022
Comparative Effectiveness of Allopurinol and Febuxostat in Gout ManagementJames R O'Dell, Mary T Brophy, Michael H Pillinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
JAMIA Open|September 6, 2021
ProjectFlow: a configurable workflow management application for point of care researchRupali Dhond, Danne Elbers, Nilla Majahalme, et al.
Health Informatics Journal|March 30, 2026
Rule-based natural language processing to extract clinical trial and research study enrollment history from unstructured notesSergey D Goryachev, Julie Tsu-Yu Wu, Eric Lin, et al.
Seminars in Arthritis and Rheumatism|August 9, 2025
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trialSamantha Kohn, Harlan Sayles, Lindsay N Helget, et al.
American Journal of Epidemiology|July 31, 2018
The Gulf War Era Cohort and Biorepository: A Longitudinal Research Resource of Veterans of the 1990-1991 Gulf War EraLara Khalil, Rebecca B McNeil, Kellie J Sims, et al.
Arthritis Care & Research|August 7, 2025
Improvements in Health-Related Quality of Life with Treat-to-Target Urate-Lowering Therapy in Gout: A Post-hoc Analysis of a Randomized Multicenter TrialAustin Barry, Bryant R England, Harlan Sayles, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter TrialAustin Barry, Lindsay N Helget, Maria Androsenko, et al.
JAMA Network Open|June 30, 2026
Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric DisordersDavid T Liebers, Tianshe He, Rebecca A Betensky, et al.
Studies in Health Technology and Informatics|August 24, 2019
Machine Learning Methods to Predict Lung Cancer Survival Using the Veterans Affairs Research Precision Oncology Data CommonsNhan V Do, Jaime C Ramos, Nathanael R Fillmore, et al.
NEJM Evidence|April 18, 2022
Comparative Effectiveness of Allopurinol and Febuxostat in Gout ManagementJames R O'Dell, Mary T Brophy, Michael H Pillinger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 11, 2013
Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trialSteven D Weisbord, Martin Gallagher, James Kaufman, et al.
Pageof 7